Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

L.F. Verdonck; A. Notenboom; D.D. de Jong; M.A. MacKenzie; G.E.G. Verhoef; M.H.H. Kramer; G.J. Ossenkoppele; J.K. Doorduijn; P. Sonneveld; G.W. van Imhoff

doi:10.1182/blood-2006-07-035709

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

Translated title of the contribution: Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

L.F. Verdonck, A. Notenboom, D.D. de Jong, M.A. MacKenzie, G.E.G. Verhoef, M.H.H. Kramer, G.J. Ossenkoppele, J.K. Doorduijn, P. Sonneveld, G.W. van Imhoff

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Original language	Undefined/Unknown
Pages (from-to)	2759-2766
Number of pages	8
Journal	Blood
Volume	109
Issue number	7
DOIs	https://doi.org/10.1182/blood-2006-07-035709
Publication status	Published - 2007

Access to Document

10.1182/blood-2006-07-035709

Cite this

Verdonck, L. F., Notenboom, A., de Jong, D. D., MacKenzie, M. A., Verhoef, G. E. G., Kramer, M. H. H., Ossenkoppele, G. J., Doorduijn, J. K., Sonneveld, P., & van Imhoff, G. W. (2007). Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). Blood, 109(7), 2759-2766. https://doi.org/10.1182/blood-2006-07-035709

@article{495bfc4e39704496af7adc69fdbd4289,

title = "Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)",

author = "L.F. Verdonck and A. Notenboom and {de Jong}, D.D. and M.A. MacKenzie and G.E.G. Verhoef and M.H.H. Kramer and G.J. Ossenkoppele and J.K. Doorduijn and P. Sonneveld and {van Imhoff}, G.W.",

year = "2007",

doi = "10.1182/blood-2006-07-035709",

language = "Undefined/Unknown",

volume = "109",

pages = "2759--2766",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

Verdonck, LF, Notenboom, A, de Jong, DD, MacKenzie, MA, Verhoef, GEG, Kramer, MHH, Ossenkoppele, GJ, Doorduijn, JK, Sonneveld, P & van Imhoff, GW 2007, 'Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)', Blood, vol. 109, no. 7, pp. 2759-2766. https://doi.org/10.1182/blood-2006-07-035709

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). / Verdonck, L.F.; Notenboom, A.; de Jong, D.D. et al.
In: Blood, Vol. 109, No. 7, 2007, p. 2759-2766.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

AU - Verdonck, L.F.

AU - Notenboom, A.

AU - de Jong, D.D.

AU - MacKenzie, M.A.

AU - Verhoef, G.E.G.

AU - Kramer, M.H.H.

AU - Ossenkoppele, G.J.

AU - Doorduijn, J.K.

AU - Sonneveld, P.

AU - van Imhoff, G.W.

PY - 2007

Y1 - 2007

U2 - 10.1182/blood-2006-07-035709

DO - 10.1182/blood-2006-07-035709

M3 - Article

C2 - 17132720

SN - 0006-4971

VL - 109

SP - 2759

EP - 2766

JO - Blood

JF - Blood

IS - 7

ER -

Verdonck LF, Notenboom A, de Jong DD, MacKenzie MA, Verhoef GEG, Kramer MHH et al. Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). Blood. 2007;109(7):2759-2766. doi: 10.1182/blood-2006-07-035709